首页> 美国卫生研究院文献>Frontiers in Oncology >Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
【2h】

Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia

机译:胚发生过程中与神经母细胞瘤相关的ALK-F1174L激活突变的表达削弱了交感神经节中神经rest祖细胞的分化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Neuroblastoma (NB) is an embryonal malignancy derived from the abnormal differentiation of the sympathetic nervous system. The Anaplastic Lymphoma Kinase (ALK) gene is frequently altered in NB, through copy number alterations and activating mutations, and represents a predisposition in NB-genesis when mutated. Our previously published data suggested that ALK activating mutations may impair the differentiation potential of neural crest (NC) progenitor cells. Here, we demonstrated that the expression of the endogenous ALK gene starts at E10.5 in the developing sympathetic ganglia (SG). To decipher the impact of deregulated ALK signaling during embryogenesis on the formation and differentiation of sympathetic neuroblasts, Sox10-Cre;LSL-ALK-F1174L embryos were produced to restrict the expression of the human ALK-F1174L transgene to migrating NC cells (NCCs). First, ALK-F1174L mediated an embryonic lethality at mid-gestation and an enlargement of SG with a disorganized architecture in Sox10-Cre;LSL-ALK-F1174L embryos at E10.5 and E11.5. Second, early sympathetic differentiation was severely impaired in Sox10-Cre;LSL-ALK-F1174L embryos. Indeed, their SG displayed a marked increase in the proportion of NCCs and a decrease of sympathetic neuroblasts at both embryonic stages. Third, neuronal and noradrenergic differentiations were blocked in Sox10-Cre;LSL-ALK-F1174L SG, as a reduced proportion of Phox2b+ sympathoblasts expressed βIII-tubulin and almost none were Tyrosine Hydroxylase (TH) positive. Finally, at E10.5, ALK-F1174L mediated an important increase in the proliferation of Phox2b+ progenitors, affecting the transient cell cycle exit observed in normal SG at this embryonic stage. Altogether, we report for the first time that the expression of the human ALK-F1174L mutation in NCCs during embryonic development profoundly disturbs early sympathetic progenitor differentiation, in addition to increasing their proliferation, both mechanisms being potential crucial events in NB oncogenesis.
机译:神经母细胞瘤(NB)是一种源自交感神经系统异常分化的胚胎恶性肿瘤。变性淋巴瘤激酶(ALK)基因在NB中经常发生改变,通过拷贝数改变和激活突变,并且在突变时代表NB发生中的易感性。我们以前发表的数据表明,ALK激活突变可能会损害神经rest(NC)祖细胞的分化潜能。在这里,我们证明了内源性ALK基因的表达始于发展中的交感神经节(SG)中的E10.5。为了破译胚胎发生过程中ALK信号转导对交感神经母细胞形成和分化的影响,产生了Sox10-Cre; LSL-ALK-F1174L胚胎,以限制人ALK-F1174L转基因的表达,使其仅能迁移到NC细胞(NCC)中。首先,在Sox10-Cre; LSL-ALK-F1174L胚胎在E10.5和E11.5处,ALK-F1174L介导了妊娠中期的胚胎致死力和SG的增大,结构紊乱。其次,Sox10-Cre; LSL-ALK-F1174L胚胎的早期交感神经分化受到严重损害。实际上,它们的SG在两个胚胎阶段都显示出NCC比例显着增加和交感神经母细胞减少。第三,Sox10-Cre; LSL-ALK-F1174L SG中神经元和去甲肾上腺素能的分化受阻,因为Phox2b + 交感细胞表达βIII-微管蛋白的比例降低,而酪氨酸羟化酶(TH)阳性几乎没有。最后,在E10.5处,ALK-F1174L介导了Phox2b + 祖细胞增殖的重要增加,从而影响了正常SG在此胚胎期观察到的瞬时细胞周期退出。总的来说,我们首次报道人ALK-F1174L突变在胚胎发育过程中在NCC中表达,除了增加它们的增殖外,还严重干扰了早期的交感祖细胞分化,这两种机制都是NB肿瘤发生中的潜在关键事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号